Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Craig Jordan

Showing results (121-130 of 218) with videos related to

Pageof 22
Sort By:
Steroids|June 21, 2014
The evolution of nonsteroidal antiestrogens to become selective estrogen receptor modulatorsV Craig Jordan, Russell McDaniel, Fadeke Agboke, et al.
Reviews in Endocrine & Metabolic Disorders|April 19, 2007
SERMs for the treatment and prevention of breast cancerRamona F Swaby, Catherine G N Sharma, V Craig Jordan
Steroids|June 15, 2014
Selective estrogen-induced apoptosis in breast cancerIfeyinwa E Obiorah, Ping Fan, Surojeet Sengupta, et al.
Breast Cancer (Tokyo, Japan)|May 9, 2007
Optimizing the antihormonal treatment and prevention of breast cancerRoshani R Patel, Catherine G N Sharma, V Craig Jordan
Current Signal Transduction Therapy|October 8, 2009
The Paradox of Oestradiol-Induced Breast Cancer Cell Growth and ApoptosisPhilipp Y Maximov, Joan S Lewis-Wambi, V Craig Jordan
The Journal of Steroid Biochemistry and Molecular Biology|January 27, 2009
Potential of l-buthionine sulfoximine to enhance the apoptotic action of estradiol to reverse acquired antihormonal resistance in metastatic breast cancerJoan S Lewis-Wambi, Ramona Swaby, Helen Kim, et al.
International Journal of Oncology|October 8, 2005
Deregulation of estrogen induced telomerase activity in tamoxifen-resistant breast cancer cellsWoo-Chan Park, Hong Liu, Jennifer Macgregor Schafer, et al.
Current Topics in Medicinal Chemistry|March 7, 2006
Estrogen receptors as therapeutic targets in breast cancerEric A Ariazi, Jennifer L Ariazi, Fernando Cordera, et al.
Cancer|April 28, 2004
Acceptance of tamoxifen chemoprevention by physicians and women at riskJulia Tchou, Nanjiang Hou, Alfred Rademaker, et al.
Journal of the National Cancer Institute|November 6, 2003
Paradoxical action of fulvestrant in estradiol-induced regression of tamoxifen-stimulated breast cancerClodia Osipo, Csaba Gajdos, Hong Liu, et al.
Pageof 22

Showing results (121-130 of 218) with videos related to

Sort By:
Pageof 22
Steroids|June 21, 2014
The evolution of nonsteroidal antiestrogens to become selective estrogen receptor modulatorsV Craig Jordan, Russell McDaniel, Fadeke Agboke, et al.
Reviews in Endocrine & Metabolic Disorders|April 19, 2007
SERMs for the treatment and prevention of breast cancerRamona F Swaby, Catherine G N Sharma, V Craig Jordan
Steroids|June 15, 2014
Selective estrogen-induced apoptosis in breast cancerIfeyinwa E Obiorah, Ping Fan, Surojeet Sengupta, et al.
Breast Cancer (Tokyo, Japan)|May 9, 2007
Optimizing the antihormonal treatment and prevention of breast cancerRoshani R Patel, Catherine G N Sharma, V Craig Jordan
Current Signal Transduction Therapy|October 8, 2009
The Paradox of Oestradiol-Induced Breast Cancer Cell Growth and ApoptosisPhilipp Y Maximov, Joan S Lewis-Wambi, V Craig Jordan
The Journal of Steroid Biochemistry and Molecular Biology|January 27, 2009
Potential of l-buthionine sulfoximine to enhance the apoptotic action of estradiol to reverse acquired antihormonal resistance in metastatic breast cancerJoan S Lewis-Wambi, Ramona Swaby, Helen Kim, et al.
International Journal of Oncology|October 8, 2005
Deregulation of estrogen induced telomerase activity in tamoxifen-resistant breast cancer cellsWoo-Chan Park, Hong Liu, Jennifer Macgregor Schafer, et al.
Current Topics in Medicinal Chemistry|March 7, 2006
Estrogen receptors as therapeutic targets in breast cancerEric A Ariazi, Jennifer L Ariazi, Fernando Cordera, et al.
Cancer|April 28, 2004
Acceptance of tamoxifen chemoprevention by physicians and women at riskJulia Tchou, Nanjiang Hou, Alfred Rademaker, et al.
Journal of the National Cancer Institute|November 6, 2003
Paradoxical action of fulvestrant in estradiol-induced regression of tamoxifen-stimulated breast cancerClodia Osipo, Csaba Gajdos, Hong Liu, et al.
Pageof 22